Report #2894036

Received Apr 24, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Apr 1, 2026
Onset: Apr 1, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	UNK	AMVB106Z	—

Symptoms (2)

Expired product administeredProduct preparation issue

Symptom narrative

Menvoe was administered using the wrong diluent; Menvoe was administered using the wrong diluent; Vaccine expired on 20-SEP-2017; This non-serious case was reported by a other health professional via sales rep and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB106Z, expiry date 30-SEP-2017) for prophylaxis. In APR-2026, the patient received Menveo (unknown arm). In APR-2026, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: Menvoe was administered using the wrong diluent), inappropriate dose of vaccine administered (Verbatim: Menvoe was administered using the wrong diluent) and expired vaccine used (Verbatim: Vaccine expired on 20-SEP-2017). The outcome of the wrong solution used in drug reconstitution, inappropriate dose of vaccine administered and expired vaccine used were not applicable. Additional Information: GSK Receipt Date: 16-APR-2026 The reporter reported that the Menveo vaccine was administered using the wrong diluent.